+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Animal Biotechnology Market - Global Forecast 2026-2032- Product Image
Animal Biotechnology Market - Global Forecast 2026-2032- Product Image
Sale

Animal Biotechnology Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5264368
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Animal Biotechnology Market is projected to reach USD 36.49 Billion in 2026. It is expected to continue growing at a CAGR of 8.68%, reaching USD 60.56 Billion by 2032.

Animal biotechnology is moving from a specialized research discipline into a core enabler of food security, animal health, sustainable livestock production, aquaculture productivity, and biomedical research. The field includes animal genomics, molecular diagnostics, reproductive biotechnology, gene editing, vaccines, biologics, microbiome solutions, transgenic and cloned animal models, and precision breeding tools used across livestock, companion animals, laboratory animals, and aquatic species.

Demand is supported by structural pressures documented by global agencies, including rising protein consumption, the need to control zoonotic diseases, antimicrobial resistance concerns, and climate-related stress on animal production systems. FAO, WHO, WOAH, and OECD evidence consistently shows that animal disease outbreaks can disrupt trade, food supply, farm income, and public health systems, making preventive animal health technologies, genomic selection, and rapid diagnostics increasingly strategic for producers, governments, veterinarians, and life science stakeholders.

Transformative Shifts in Animal Biotechnology

The animal biotechnology landscape is being reshaped by the convergence of genomics, synthetic biology, automation, and data-led animal health management. Genomic selection is now widely used in dairy, poultry, swine, and aquaculture breeding programs to improve productivity, disease resistance, fertility, feed efficiency, and resilience, while CRISPR-based gene editing is accelerating research into traits that can reduce disease susceptibility, improve animal welfare, and support more sustainable production systems.

Another transformative shift is the movement from reactive treatment to preventive and predictive animal health. Rapid PCR, sequencing-based diagnostics, recombinant vaccines, monoclonal antibodies, and herd-level surveillance systems are enabling earlier intervention. At the same time, regulatory scrutiny, consumer acceptance, animal welfare expectations, antimicrobial stewardship, and traceability requirements are shaping commercialization pathways for genetically engineered animals and biotechnology-derived products.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding the impact of animal biotechnology by improving the speed, accuracy, and scalability of discovery and field deployment. AI-driven genomic analysis helps identify markers linked to economically important traits, while machine learning models can support breeding decisions by integrating phenotype, genotype, feed, environment, and health records. In veterinary medicine, AI is increasingly applied to image interpretation, pathogen detection, outbreak modeling, pharmacovigilance, and precision dosing research.

The cumulative effect is a shorter innovation cycle across animal biotechnology. AI-enabled laboratories can prioritize vaccine antigens, optimize biologics development, and interpret high-throughput sequencing data more efficiently. On farms and in aquaculture systems, AI tools connected to sensors, cameras, wearables, electronic identification, and diagnostics support early disease detection and welfare monitoring, helping reduce losses and improve productivity when implemented with validated datasets, strong cybersecurity, interoperable data systems, and transparent governance.

Key Regional Insights

Asia-Pacific is a high-priority region for animal biotechnology, driven by large animal protein demand, aquaculture scale, poultry and swine intensification, and government-backed biotechnology programs in China, India, Japan, South Korea, and Australia. The region is increasingly focused on vaccines, molecular diagnostics, swine biosecurity, shrimp and fish health, genomic selection, and reproductive technologies to improve productivity and reduce disease-related losses across diverse production systems.

North America remains a leading region for animal biotechnology due to advanced veterinary biopharma capabilities, strong university research, established livestock genetics infrastructure, and regulatory experience with biotechnology-derived animal products. The United States and Canada benefit from large commercial livestock industries, companion animal health spending, genomic evaluation systems, and mature disease surveillance networks that support precision breeding, veterinary biologics, and One Health preparedness.

Latin America, led by Brazil and Mexico, is adopting animal genetics, reproductive technologies, vaccines, and diagnostics to improve export competitiveness in beef, poultry, dairy, and swine. Europe is shaped by strong animal welfare rules, rigorous biosafety oversight, and public investment in genomics, vaccines, alternatives to antimicrobials, and One Health surveillance, with the European Union’s regulatory framework influencing adoption timelines. The Middle East is investing in food security, veterinary diagnostics, biosecure production, camel health, and small ruminant health, while Africa’s opportunity is linked to disease control, heat-tolerant breeds, vaccine access, molecular diagnostics, and productivity improvement for smallholder and commercial livestock systems.

Key Group Insights

ASEAN is gaining relevance in animal biotechnology through poultry, aquaculture, and swine production, especially as governments strengthen disease surveillance and biosecurity after major transboundary disease events. The region’s needs are closely tied to rapid diagnostics, vaccines, breeding improvement, aquaculture health, and practical technologies that can be deployed across both intensive and smallholder systems.

GCC markets are focused on food security, import substitution, high-value animal health, and biotechnology applications suited to arid environments and regional livestock systems, including camel, dairy, poultry, and small ruminant production. The European Union provides one of the most influential policy environments for animal biotechnology through harmonized standards for veterinary medicines, food safety, animal welfare, environmental risk assessment, and antimicrobial reduction, creating a demanding but high-value environment for compliant diagnostics, vaccines, and breeding technologies.

BRICS countries are critical to production scale and technology adoption, with China, India, and Brazil playing major roles in livestock, aquaculture, vaccine manufacturing, genomics, and disease control. G7 countries are central to animal biotechnology innovation because they combine advanced research infrastructure, mature veterinary pharmaceutical ecosystems, strong intellectual property systems, and regulatory science. NATO members add a biosecurity dimension, with zoonotic disease preparedness, supply chain resilience, laboratory capability, and surveillance systems becoming increasingly important for national security and food system resilience planning.

Key Country Insights

The United States leads in animal biotechnology commercialization through advanced animal genomics, veterinary biologics, companion animal therapeutics, molecular diagnostics, and academic-industry collaboration. Canada is strong in livestock genetics, vaccine research, dairy and beef innovation, and animal health surveillance, while Mexico is expanding veterinary diagnostics and production technologies linked to poultry, beef, dairy, and swine supply chains. Brazil is a major platform because of its global role in beef and poultry exports, supported by breeding, reproductive technologies, vaccines, and biosecurity investment.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain strong capabilities in veterinary research, livestock genetics, animal welfare science, diagnostics, and vaccine development, although adoption of gene-edited animals depends on evolving regulatory pathways and consumer acceptance. Russia remains relevant in livestock disease control, domestic vaccine capacity, veterinary surveillance, and agricultural biotechnology priorities.

China is scaling animal biotechnology through genomics, gene editing research, vaccines, swine biosecurity, disease surveillance, and aquaculture innovation. India’s opportunity is tied to dairy productivity, animal vaccines, reproductive technologies, molecular diagnostics, and disease control for a large livestock base. Japan and South Korea emphasize precision animal health, advanced diagnostics, biotechnology research, biosecurity, and high-value livestock systems, while Australia is important for livestock genetics, biosecurity, reproductive biotechnology, disease preparedness, and export-oriented animal health standards.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize validated, field-ready animal biotechnology solutions that address measurable pain points such as disease losses, reproductive efficiency, feed conversion, animal welfare, heat stress resilience, aquaculture mortality, and antimicrobial reduction. Organizations can improve adoption by pairing biotechnology products with diagnostics, data platforms, training, veterinary support, and outcome-based evidence for producers, veterinarians, regulators, and public health stakeholders.

Strategic investment should focus on genomic selection, rapid diagnostics, next-generation vaccines, biologics, microbiome products, reproductive biotechnology, aquaculture health, and AI-enabled decision support. Leaders should also build regulatory affairs capabilities early, establish transparent animal welfare and biosafety documentation, protect genomic and farm data, validate claims through field trials, and form partnerships with universities, reference laboratories, producer groups, and public health agencies to strengthen credibility and market access.

Research Methodology

Research methodology is based on secondary research that synthesizes publicly available and institutionally recognized sources, including FAO, WOAH, WHO, OECD, USDA, FDA, EMA, EFSA, national agriculture departments, peer-reviewed journals, patent databases, regulatory publications, and veterinary industry sources. The analysis focuses on verifiable trends in animal genomics, veterinary biologics, molecular diagnostics, reproductive biotechnology, gene editing, aquaculture biotechnology, microbiome science, and AI-enabled animal health.

The research approach evaluates technology maturity, regulatory direction, regional production systems, disease burden, commercialization readiness, animal welfare considerations, biosecurity priorities, and adoption drivers. Insights are triangulated across scientific evidence, public policy, regulatory activity, market deployment patterns, and industry use cases to support an authoritative view of the animal biotechnology landscape without relying on unverified claims, market sizing, market share, or forecasting.

Conclusion

Animal biotechnology is becoming a strategic pillar for resilient animal agriculture, veterinary medicine, aquaculture, biomedical research, and sustainable protein production. As disease pressure, climate risk, antimicrobial stewardship, zoonotic threats, and food security concerns intensify, biotechnology-enabled breeding, diagnostics, vaccines, biologics, and AI-supported analytics will play a larger role in improving animal productivity, health outcomes, and welfare.

The next phase of advancement will be defined by responsible innovation. Organizations that combine scientific validation, regulatory readiness, ethical governance, biosafety, transparent data practices, and clear economic value for producers and veterinarians will be best positioned to lead in the animal biotechnology landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Animal Biotechnology Market, by Product Type
7.1. Introduction
7.2. Recombinant Proteins
7.2.1. Antibodies
7.2.2. Enzymes
7.2.2.1. Lipases
7.2.2.2. Phytases
7.2.2.3. Proteases
7.2.3. Growth Hormones
7.3. Vaccines
7.3.1. DNA Vaccines
7.3.2. Inactivated Vaccines
7.3.3. Live Attenuated Vaccines
7.3.4. Subunit Vaccines
8. Animal Biotechnology Market, by Technology
8.1. Introduction
8.2. Cell Culture
8.2.1. Avian Cell Culture
8.2.2. Insect Cell Culture
8.2.3. Mammalian Cell Culture
8.3. Genetic Engineering
8.3.1. Gene Editing
8.3.2. Gene Synthesis
8.3.3. Transgenic Technology
8.4. PCR And DNA Sequencing
8.4.1. Next-Generation Sequencing
8.4.2. PCR Kits
8.4.3. Sanger Sequencing
9. Animal Biotechnology Market, by Animal Type
9.1. Introduction
9.2. Livestock
9.2.1. Cattle
9.2.2. Poultry
9.2.3. Swine
9.3. Companion Animals
9.3.1. Dogs
9.3.2. Cats
10. Animal Biotechnology Market, by Application
10.1. Introduction
10.2. Diagnostics
10.2.1. ELISA Kits
10.2.2. Lateral Flow Assays
10.2.3. PCR-Based Tests
10.3. Drug Discovery
10.3.1. Lead Optimization
10.3.2. Preclinical Testing
10.3.3. Target Identification
10.4. Feed Additives
10.4.1. Carbohydrases
10.4.2. Phytases
10.4.3. Proteases
11. Animal Biotechnology Market, by End-User
11.1. Introduction
11.2. Animal Farms
11.3. Contract Research Organizations
11.4. Pharmaceutical Companies
11.5. Research Laboratories
12. Animal Biotechnology Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Animal Biotechnology Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Animal Biotechnology Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abaxis, Inc.
16.2. Bio-Rad Laboratories, Inc.
16.3. BioChek B.V.
16.4. Biogénesis Bagó S.A.
16.5. Bioniche Life Sciences Inc.
16.6. Boehringer Ingelheim International GmbH
16.7. Ceva Santé Animale
16.8. Covetrus, Inc.
16.9. Creative Biolabs, Inc.
16.10. Dechra Pharmaceuticals PLC
16.11. Elanco Animal Health Incorporated
16.12. Genus plc
16.13. Henry Schein Animal Health
16.14. Heska Corporation
16.15. Hester Biosciences Limited
16.16. IDEXX Laboratories, Inc.
16.17. IDvet SAS
16.18. ImmuCell Corporation
16.19. Indian Immunologicals Limited
16.20. INDICAL Bioscience GmbH
16.21. Intas Pharmaceuticals Limited
16.22. Merck & Co., Inc.
16.23. Neogen Corporation
16.24. Neovet Diagnostics Pvt. Ltd.
16.25. Pharmgate Animal Health LLC
16.26. Phibro Animal Health Corporation
16.27. Randox Laboratories Ltd.
16.28. Recombinetics, Inc.
16.29. Santa Cruz Biotechnology, Inc.
16.30. Sequent Scientific Limited
16.31. Thermo Fisher Scientific Inc.
16.32. Trans Ova Genetics, L.C.
16.33. Vetoquinol S.A.
16.34. Virbac S.A.
16.35. Zoetis Inc.
List of Figures
FIGURE 1. GLOBAL ANIMAL BIOTECHNOLOGY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ANIMAL BIOTECHNOLOGY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ANIMAL BIOTECHNOLOGY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ANIMAL BIOTECHNOLOGY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL ANIMAL BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ANTIBODIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ANTIBODIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ANTIBODIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL LIPASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL LIPASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL LIPASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL PHYTASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL PHYTASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL PHYTASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL PROTEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL PROTEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL PROTEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL GROWTH HORMONES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL GROWTH HORMONES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL GROWTH HORMONES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL DNA VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL DNA VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL DNA VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CELL CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CELL CULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL AVIAN CELL CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL AVIAN CELL CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL AVIAN CELL CULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL INSECT CELL CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL INSECT CELL CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL INSECT CELL CULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL MAMMALIAN CELL CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL MAMMALIAN CELL CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL MAMMALIAN CELL CULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL GENETIC ENGINEERING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL GENETIC ENGINEERING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL GENETIC ENGINEERING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL GENE EDITING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL GENE EDITING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL GENE EDITING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL TRANSGENIC TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL TRANSGENIC TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL TRANSGENIC TECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL PCR AND DNA SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL PCR AND DNA SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL PCR AND DNA SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL PCR KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL PCR KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL PCR KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL SANGER SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL SANGER SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL SANGER SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL LIVESTOCK MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL LIVESTOCK MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL LIVESTOCK MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL CATTLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL POULTRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL SWINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL SWINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL DOGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL DOGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL CATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL CATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL ELISA KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL ELISA KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL ELISA KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL PCR-BASED TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL PCR-BASED TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL PCR-BASED TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL LEAD OPTIMIZATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL LEAD OPTIMIZATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL LEAD OPTIMIZATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL PRECLINICAL TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL PRECLINICAL TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL PRECLINICAL TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL TARGET IDENTIFICATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL TARGET IDENTIFICATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL TARGET IDENTIFICATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL FEED ADDITIVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL FEED ADDITIVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL FEED ADDITIVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL CARBOHYDRASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL CARBOHYDRASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL CARBOHYDRASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL PHYTASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL PHYTASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL PHYTASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL PROTEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL PROTEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL PROTEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL ANIMAL FARMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL ANIMAL FARMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL ANIMAL FARMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2017-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2017-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2017-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 167. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 168. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 169. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2017-2032 (USD MILLION)
TABLE 170. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 171. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 172. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 173. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 174. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2017-2032 (USD MILLION)
TABLE 175. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2017-2032 (USD MILLION)
TABLE 176. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 177. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 178. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 179. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 180. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 181. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 182. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 183. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 184. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 185. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 186. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2017-2032 (USD MILLION)
TABLE 187. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 188. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 189. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 190. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 191. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2017-2032 (USD MILLION)
TABLE 192. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2017-2032 (USD MILLION)
TABLE 193. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 194. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 195. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 196. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 197. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 198. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 199. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 200. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 201. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 202. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 203. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2017-2032 (USD MILLION)
TABLE 204. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 205. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 206. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 207. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 208. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2017-2032 (USD MILLION)
TABLE 209. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2017-2032 (USD MILLION)
TABLE 210. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 211. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 212. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 213. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 214. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 215. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 216. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 217. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 218. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 219. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 220. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2017-2032 (USD MILLION)
TABLE 221. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 222. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 223. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 224. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 225. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2017-2032 (USD MILLION)
TABLE 226. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2017-2032 (USD MILLION)
TABLE 227. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 228. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 229. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 230. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 231. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 232. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 233. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 234. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 235. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 236. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 237. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2017-2032 (USD MILLION)
TABLE 238. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 239. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 240. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 241. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 242. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2017-2032 (USD MILLION)
TABLE 243. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2017-2032 (USD MILLION)
TABLE 244. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 245. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 246. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 247. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 248. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 249. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 250. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 251. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 252. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 253. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 254. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 255. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2017-2032 (USD MILLION)
TABLE 256. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 257. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 258. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 259. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 260. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2017-2032 (USD MILLION)
TABLE 261. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2017-2032 (USD MILLION)
TABLE 262. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 263. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 264. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 265. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 266. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 267. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 268. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 269. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 270. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 271. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 272. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2017-2032 (USD MILLION)
TABLE 273. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 274. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 275. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 276. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 277. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2017-2032 (USD MILLION)
TABLE 278. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2017-2032 (USD MILLION)
TABLE 279. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 280. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 281. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 282. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 283. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 284. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 285. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 286. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 288. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 289. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2017-2032 (USD MILLION)
TABLE 290. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 291. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 292. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 293. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 294. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2017-2032 (USD MILLION)
TABLE 295. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2017-2032 (USD MILLION)
TABLE 296. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 297. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 298. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 299. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 300. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 301. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 302. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 303. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 304. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 305. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 306. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2017-2032 (USD MILLION)
TABLE 307. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 308. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 309. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 310. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 311. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2017-2032 (USD MILLION)
TABLE 312. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2017-2032 (USD MILLION)
TABLE 313. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 314. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 315. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 316. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 317. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 318. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 319. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 320. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 321. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 322. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 323. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2017-2032 (USD MILLION)
TABLE 324. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 325. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 326. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 327. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 328. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2017-2032 (USD MILLION)
TABLE 329. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2017-2032 (USD MILLION)
TABLE 330. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 331. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 332. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 333. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 334. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 335. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 336. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 337. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 338. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 339. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 340. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2017-2032 (USD MILLION)
TABLE 341. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 342. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 343. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 344. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 345. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2017-2032 (USD MILLION)
TABLE 346. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2017-2032 (USD MILLION)
TABLE 347. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 348. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 349. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 350. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 351. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 352. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2017-2032 (USD MILLION)
TABLE 353. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 354. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 355. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 356. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 357. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 358. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2017-2032 (USD MILLION)
TABLE 359. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2017-2032 (USD MILLION)
TABLE 360. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 361. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 362. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2017-2032 (USD MILLION)
TABLE 363. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2017-2032 (USD MILLION)
TABLE 364. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2017-2032 (USD MILLION)
TABLE 365. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 366. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 367. UNITED

Companies Mentioned

  • Abaxis, Inc.
  • Bio-Rad Laboratories, Inc.
  • BioChek B.V.
  • Biogénesis Bagó S.A.
  • Bioniche Life Sciences Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Covetrus, Inc.
  • Creative Biolabs, Inc.
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Genus plc
  • Henry Schein Animal Health
  • Heska Corporation
  • Hester Biosciences Limited
  • IDEXX Laboratories, Inc.
  • IDvet SAS
  • ImmuCell Corporation
  • Indian Immunologicals Limited
  • INDICAL Bioscience GmbH
  • Intas Pharmaceuticals Limited
  • Merck & Co., Inc.
  • Neogen Corporation
  • Neovet Diagnostics Pvt. Ltd.
  • Pharmgate Animal Health LLC
  • Phibro Animal Health Corporation
  • Randox Laboratories Ltd.
  • Recombinetics, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Sequent Scientific Limited
  • Thermo Fisher Scientific Inc.
  • Trans Ova Genetics, L.C.
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 36.49 Billion
Forecasted Market Value ( USD ) by 2032 $ 60.56 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned35

Related Topics

Related Reports

Animal Biotechnology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Animal Biotechnology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 180 Pages
  • Global
From
Animal Biotechnology Market Report 2026 - Product Image

Animal Biotechnology Market Report 2026

  • Report
  • 250 Pages
  • Global
From
International Journal of Animal Biotechnology and Applications - Product Image

International Journal of Animal Biotechnology and Applications

  • Journal Icon Journal
  • Global
From
Food Biotechnology Market - Global Forecast 2026-2032 - Product Image

Food Biotechnology Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Agricultural Biotechnology Market - Global Forecast 2026-2032 - Product Image

Agricultural Biotechnology Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From

About the Market

Animal biotechnology is a branch of biotechnology that focuses on the application of genetic engineering and other molecular biology techniques to animals. It is used to modify the genetic makeup of animals to produce desired traits, such as disease resistance, improved growth, and improved production of food and other products. Animal biotechnology is used in a variety of industries, including agriculture, pharmaceuticals, and veterinary medicine. Animal biotechnology is used to develop new animal models for research, to improve animal health and welfare, and to produce new animal-derived products. It is also used to develop new animal-derived pharmaceuticals, such as vaccines and antibodies, and to produce transgenic animals for use in biomedical research. Animal biotechnology is a rapidly growing field, with many companies investing in research and development. Examples of companies in the animal biotechnology market include Genus plc, Recombinetics, Inc., and Genocea Biosciences, Inc. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.